Marcello Maugeri‐Saccà

National Cancer Institute — Malaysia

Medicine · Health Sciences

37h-index4.9kcitations157works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(42), Cancer Immunotherapy and Biomarkers(40), Lung Cancer Research Studies(26), Hippo pathway signaling and YAP/TAZ(18), Cancer-related Molecular Pathways(16)

Publications157 total

TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
Journal of Thoracic Oncology·2026
Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
International Journal of Molecular Sciences·2026Open Access
PT2.11.01 Predictors of Response to PD-(L)1 Blockade in Patients With Oncogene-Driver Negative NSCLC Without History of Tobacco Use
Journal of Thoracic Oncology·2025
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review
Biology Direct·2025· 5 citedOpen Access
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
Annals of Oncology·2025· 4 citedOpen Access
Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as potential targets
Journal of Translational Medicine·2025· 2 citedOpen Access
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
Annals of Oncology·2024· 11 citedOpen Access
Supplementary Table S5 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S9 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Data from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Table S3 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S3 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S2 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S1 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S7 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S14 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S20 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Figure S19 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Table S6 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
Supplementary Table S1 from Transcriptional Phenocopies of Deleterious <i>KEAP1</i> Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Ruggero De Maria(33), Patrizia Vici(31), Maddalena Barba(30), Laura Pizzuti(29), Luigi Di Lauro(20), Domenico Sergi(18), Gennaro Ciliberto(16), Paolo Marchetti(15), Teresa Gamucci(15), Clara Natoli(15), Marcella Mottolese(13), Isabella Sperduti(13), Francesca Sperati(12), Marco Mazzotta(9), Eriseld Krasniqi(9), Giuseppe Sanguineti(9), Federica Tomao(8), Luca Moscetti(8), Stefano Scalera(7), Irene Terrenato(7)